Prof. Manfredi Rizzo, MD, PhD
Prof. Manfredi Rizzo, MD, PhD
DIBIMIS, University of Palermo, Italy; School of Medicine, University of South Carolina, USA
Verified email at
TitleCited byYear
Extensive clinical experience
E Carmina, F Rosato, A Jannı, M Rizzo, RA Longo
The Journal of Clinical Endocrinology & Metabolism 91 (1), 2-6, 2006
Low-density lipoprotein size and cardiovascular risk assessment
M Rizzo, K Berneis
Qjm 99 (1), 1-14, 2006
“European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses
D P Mikhailidis, M Elisaf, M Rizzo, K Berneis, B Griffin, A Zambon, ...
Current vascular pharmacology 9 (5), 533-571, 2011
An update on the role of markers of inflammation in atherosclerosis
E Corrado, M Rizzo, G Coppola, K Fattouch, G Novo, I Marturana, ...
Journal of atherosclerosis and thrombosis, 0912220131-0912220131, 2009
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis
RA Wild, M Rizzo, S Clifton, E Carmina
Fertility and sterility 95 (3), 1073-1079. e11, 2011
Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins
DL Tribble, M Rizzo, A Chait, DM Lewis, PJ Blanche, RM Krauss
The American journal of medicine 110 (2), 103-110, 2001
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study
E Corrado, M Rizzo, R Tantillo, I Muratori, F Bonura, G Vitale, S Novo
Stroke 37 (2), 482-486, 2006
Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis
L Nibali, N Tatarakis, I Needleman, YK Tu, F D'Aiuto, M Rizzo, N Donos
The Journal of Clinical Endocrinology & Metabolism 98 (3), 913-920, 2013
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials
M Banach, C Serban, A Sahebkar, S Ursoniu, J Rysz, P Muntner, PP Toth, ...
Mayo Clinic Proceedings 90 (1), 24-34, 2015
Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome
K Berneis, M Rizzo, V Lazzaroni, F Fruzzetti, E Carmina
The Journal of Clinical Endocrinology & Metabolism 92 (1), 186-189, 2007
Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy
G Di Lorenzo, P Mansueto, ML Pacor, M Rizzo, F Castello, N Martinelli, ...
Journal of Allergy and Clinical Immunology 123 (5), 1103-1110. e4, 2009
Analysis of vitamin D levels in patients with and without statin-associated myalgia—a systematic review and meta-analysis of 7 studies with 2420 patients
M Michalska-Kasiczak, A Sahebkar, DP Mikhailidis, J Rysz, P Muntner, ...
International journal of cardiology 178, 111-116, 2015
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches
D Nikolic, N Katsiki, G Montalto, ER Isenovic, DP Mikhailidis, M Rizzo
Nutrients 5 (3), 928-948, 2013
Atherogenic dyslipidemia and oxidative stress: a new look
M Rizzo, J Kotur-Stevuljevic, K Berneis, G Spinas, GB Rini, ...
Translational Research 153 (5), 217-223, 2009
Small, dense low‐density lipoproteins (LDL) are predictors of cardio‐and cerebro‐vascular events in subjects with the metabolic syndrome
M Rizzo, V Pernice, A Frasheri, G Di Lorenzo, GB Rini, GA Spinas, ...
Clinical endocrinology 70 (6), 870-875, 2009
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy—a meta-analysis of 11 randomized controlled trials involving 21,295 participants
M Barylski, S Nikfar, DP Mikhailidis, PP Toth, P Salari, KK Ray, ...
Pharmacological research 72, 35-44, 2013
Should we measure routinely the LDL peak particle size?
M Rizzo, K Berneis
International journal of cardiology 107 (2), 166-170, 2006
Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention?
M Rizzo, K Berneis
Journal of atherosclerosis and thrombosis 12 (5), 237-239, 2005
The role of fibrate treatment in dyslipidemia: an overview
N Katsiki, D Nikolic, G Montalto, M Banach, DP Mikhailidis, M Rizzo
Current pharmaceutical design 19 (17), 3124-3131, 2013
Cystatin C levels are decreased in acute myocardial infarction: effect of cystatin C G73A gene polymorphism on plasma levels
D Noto, AB Cefalu, CM Barbagallo, A Pace, M Rizzo, G Marino, ...
International journal of cardiology 101 (2), 213-217, 2005
The system can't perform the operation now. Try again later.
Articles 1–20